Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.146 EUR | +4.29% | +11.45% | -45.52% |
Business Summary
Number of employees: 24
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals
100.0
%
| 1,092 | 100.0 % | 617 | 100.0 % | -43.50% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China and Other
86.9
%
| 768 | 70.4 % | 536 | 86.9 % | -30.21% |
Japan
13.1
%
| 323 | 29.6 % | 81 | 13.1 % | -74.92% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yoshihiro Arai
CEO | Chief Executive Officer | 63 | 01/07/01 |
Koji Shinozaki
FOU | Founder | - | 01/06/01 |
Toshio Miyashita
DFI | Director of Finance/CFO | 56 | 01/14/01 |
Investor Relations Contact | - | - | |
Yasuaki Manabe
SAM | Sales & Marketing | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yiu Kwan Lau
BRD | Director/Board Member | 69 | 01/14/01 |
Yoshihiro Arai
CEO | Chief Executive Officer | 63 | 01/07/01 |
Toshio Miyashita
DFI | Director of Finance/CFO | 56 | 01/14/01 |
Norikazu Eiki
BRD | Director/Board Member | 76 | 01/16/01 |
Jiro Mizukawa
BRD | Director/Board Member | 71 | 30/20/30 |
Stanley Lau
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 193,494,010 | 158,049,312 ( 81.68 %) | 430,910 ( 0.2227 %) | 81.68 % |
Company contact information
Solasia Pharma KK
Sumitomo Fudosan Shiba-Koen Tower 4F 2-11-1 Shiba-koen
105-0011, Tokyo
+81 3 5843 8045
http://www.solasia.co.jpSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.26% | 89.46B | |
+2.76% | 40.74B | |
-9.06% | 33.03B | |
+55.32% | 24.68B | |
-16.61% | 15.12B | |
-9.14% | 12.81B | |
-12.11% | 11.79B | |
-43.61% | 11.64B | |
+7.79% | 8.9B |
- Stock Market
- Equities
- 4597 Stock
- 9SO Stock
- Company Solasia Pharma K.K.